NPPA Fixes Prices of 42 Popular Drugs Including Empagliflozin & Metformin, Dapagliflozin & Glimepiride; Details Farhat Nasim12 Feb 2025 8:31 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of 42 essential drugs,...
Drug Alert: CDSCO Flags 51 Formulations As Not Of Standard Quality Susmita Roy25 Jan 2025 6:00 PM ISTNew Delhi: In its latest drug alert, the apex drug regulatory body, the Central Drug Standard Control Organization (CDSCO), has flagged 41 medicine...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
Indian Pharma Market registers 8 percent surge to Rs 17,937 Crore in January 2024: IQVIA Farhat Nasim19 Feb 2024 7:19 PM ISTNew Delhi: In an impressive kickoff to 2024, the Indian pharmaceutical market surged by 8%, reaching a substantial Rs 17,937 crore in January, as per...
NPPA Fixes Retail Price of 51 Formulations, Details Dr. Divya Colin18 Sept 2023 6:00 PM ISTNew Delhi: Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA), the Ministry of Chemicals and Fertilizers,...
Indian Pharma Market registers 11 percent growth in April: IQVIA Farhat Nasim24 May 2023 11:51 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has reported double-digit growth of 11 percent for the month of April 2023, according to IQVIA.On a...
IPM grew 19 percent in March, brands like Calpol, Augmentin observed highest growth: IQVIA Farhat Nasim12 April 2023 6:09 PM ISTNew Delhi: The Indian pharmaceutical market reported double-digit growth of 19 percent in the month of March 2023, according to IQVIA. The...
Macleod Pharma gets CDSCO panel conditional nod to study FDC Sitagliptin, Metformin, Glimepiride Susmita Roy28 March 2022 7:02 PM ISTNew Delhi: Pharmaceutical major, Macleods Pharmaceuticals has got the go-head from the Subject Expert Committee (SEC) of the Central Drug Standard...
Indian Pharma sees decline in August 2020, anti-infectives, respiratory segments see major slumps: AIOCD-AWACS report Farhat Nasim12 Sept 2020 1:08 PM ISTNew Delhi: Amid the ongoing COVID-19 crisis, the month of August remained unfavorable for the Indian pharmaceutical market as data from market...
